The Drug Eluting Stents Center

Filter Your Results




Combining a Drug-Coated Balloon and a Bare-Metal Stent: The REsponse Adapted Combination Therapy (REACT) Strategy

Koen Deloose, MD, and B. Patrice Mwipatayi, MD, MMed, MClinEd, FCS, FRACS

September 2018—Allowing vessel response to guide appropriate treatment for SFA disease.

Assessing the Economic Impact of Peripheral Interventions

Yann Gouëffic, MD, PhD; and Valéry-Pierre Riche

September 2018—The difficulties in weighing cost-effectiveness in treatment algorithms remain.

The Importance of Vessel Preparation

Ralf Langhoff, MD

September 2018—Properly preparing lesions before use of drug-eluting technologies has become a crucial step of the treatment algorithm.

Bioresorbable Stent Technology for Femoropopliteal Disease Treatment: Where Do We Stand?

Sabine Steiner, MD; Andrej Schmidt, MD; and Dierk Scheinert, MD

September 2018—Appraising the current literature on bioresorbable technology use in the SFA, what can be learned from the coronary experience, and the future of bioresorbable stents in this anatomy.

Inert Technology: Actively Making a Difference in Drug-Eluting Stent Designs

November 2017—QualiMed’s sirolimus-eluting coronary stent is available under CE Mark only and is not approved in the United States. First-generation drug-eluting stents (DESs) deli…

The State of Peripheral Drug‑Eluting Technologies

Michael R. Jaff, DO

September 2017— When comparing the myriad options available for the treatment of patients with peripheral artery disease (PAD) today compared to just 1 decade ago, it is a testimony to ph…

Interim Results From the Muenster Postmarket All-Comers Registry

Theodosios Bisdas, MD, PhD

September 2017—A look at the latest data on use of the Eluvia drug-eluting stent in challenging SFA lesions.

Economic Analysis Supporting the Use of Drug-Eluting Technologies in the Femoropopliteal Artery

Konstantinos Katsanos, MSc, MD, PhD, EBIR

September 2017—These evolving modern therapies are showing promise in reducing health care costs while offering better outcomes.




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.